Dr. Josep Dalmau Dalmau Obrador

Meet Dr. Josep Dalmau Obrador, a distinguished neurologist and neuro-oncologist based at Sant Joan de Déu Hospital in Barcelona, Spain. Boasting an impressive 25 years of experience in the field, Dr. Dalmau is renowned for his expertise in autoimmune encephalitis, paraneoplastic syndromes, and neuro-oncology. He holds specialization in addressing a spectrum of neurological issues, with a notable focus on conditions such as astrocytoma, brain tumors, brain cysts, craniostenosis, edema of the brain, arachnoiditis, encephalopathy, and epilepsy. Dr. Dalmau's academic journey began with the completion of his medical education at the University of Barcelona in 1978, followed by a residency in neurology at Santa Creu I Sant Pau Hospital. Over the years, he has made significant contributions to neurology research, serving as a senior cancer researcher at Memorial Sloan Kettering Cancer Center in New York and holding various positions at esteemed institutions, including the University of Arkansas, the University of Philadelphia, and the National Institute of Health (NIH) since 2013. A distinguished member of several prestigious medical societies, Dr. Dalmau is associated with organizations such as the American Academy of Medicine, the Spanish Society of Neurology (SEN), the American Academy of Neurology (AAN), the Catalan Society of Neurology (SCN), the American Neurological Association (ANA), the European School of Neuroimmunology (ESNI), the French Society of Neurology (SFN), and the International Society of Neuroimmunology (ISNI). Dr. Dalmau's remarkable contributions to the field include the discovery of ten autoimmune diseases, labeled as autoimmune encephalopathies, and his role as an editor of the Neuroimmunology and Neuroinflammation journal. Recognized for his outstanding contributions, he was honored with the Rey Jaime I Award in 2017 and received a career achievement award in 2013. Dr. Josep Dalmau Obrador continues to advance medical knowledge through his extensive research and innovative approaches to treating autoimmune diseases.